Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/1999
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065941A1 Insulin analogue
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065937A2 Truncated apaf-1 and methods of use thereof
12/23/1999WO1999065936A2 Composition for the treatement of immune deficiencies and methods for its preparation and use
12/23/1999WO1999065935A2 Fas peptides and antibodies for modulating apoptosis
12/23/1999WO1999065931A1 Non-enzymatic chemical amidation process
12/23/1999WO1999065929A1 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx
12/23/1999WO1999065928A2 Polynucleotide population isolated from non-metastatic and metastatic breast tumor tissues
12/23/1999WO1999065924A2 Preparation and use of superior vaccines
12/23/1999WO1999065712A2 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999WO1999065530A1 NrdD
12/23/1999WO1999065524A1 LZ-CD23 CHIMERA FOR INHIBITION OF IgE-MEDIATED ALLERGIC DISEASE
12/23/1999WO1999065522A1 Hla binding peptides and their uses
12/23/1999WO1999065520A1 Egg surface proteins and methods for use for modulating fertility
12/23/1999WO1999065513A2 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999WO1999065512A1 Medicinal compositions containing fibroblast growth factor-related peptides
12/23/1999WO1999065511A2 Composition and method for treatment of pseudomonas infection
12/23/1999WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999WO1999065450A2 Immunosuppressive agents that inhibit calcineurin function and uses thereof
12/23/1999WO1999055832A3 Nucleic acid encoding rate agouti related protein
12/23/1999WO1999055728A3 Ese genes and proteins
12/23/1999WO1999054493A3 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
12/23/1999WO1999053043A3 Herpes simplex virus latency associated transcript polypeptides
12/23/1999WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999WO1999051629A3 New compounds for dna-transfection
12/23/1999WO1999049881A3 Application of hsp70 proteins
12/23/1999WO1999047558A3 T cell costimulatory proteins, sequences and uses thereof
12/23/1999WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999WO1999042589A3 Insecticidal toxins from photorhabdus
12/23/1999WO1999042578A3 Modulation of cell proliferation, methods and reagents
12/23/1999WO1999038972A3 Human genes and gene expression products ii
12/23/1999WO1999033982A3 Human genes and gene expression products i
12/23/1999WO1999033871A3 Essential bacterial genes and their use
12/23/1999WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999WO1998051791A9 Gene causative of rheumatoid arthritis, method for the diagnosis of rheumatoid arthritis, and method for the determination of factors causing rheumatoid arthritis
12/23/1999DE19829660C1 Transgenic non-human mammal useful for testing compounds for anticancer activity
12/23/1999DE19812375C1 Für Tumorsuppressorproteine codierende Nucleinsäure, Tumorsuppressorproteine, Verfahren zu deren Herstellung, Antikörper gegen Tumorsuppressorproteine und Verwendung dieser Gegenstände For nucleic acid coding for tumor suppressor proteins, tumor suppressor proteins, processes for their preparation, to antibodies against tumor suppressor proteins and use of these articles
12/23/1999CA2335452A1 Preparation and use of superior vaccines
12/23/1999CA2335184A1 Cyclic somatostatin analogs
12/23/1999CA2334905A1 Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents
12/23/1999CA2334859A1 Insulin analogue
12/23/1999CA2334165A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999CA2333602A1 Expression vector for use in a one-step purification protocol
12/23/1999CA2332563A1 Glycosulfopeptides and methods of synthesis and use thereof
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331880A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999CA2331834A1 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
12/23/1999CA2331384A1 Nucleic acid transfer phage
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999CA2331330A1 Non-enzymatic chemical amidation process
12/23/1999CA2331266A1 Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx
12/23/1999CA2331253A1 Immunomodulator polypeptide, zsig57
12/23/1999CA2331197A1 Hiv virus mimotopes
12/23/1999CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999CA2330939A1 Variant type ii tgf-beta receptor fusion proteins and methods
12/23/1999CA2330842A1 Truncated apaf-1 and methods of use thereof
12/23/1999CA2330824A1 Hla binding peptides and their uses
12/23/1999CA2330527A1 Erythropoietin analog-human serum albumin fusion
12/23/1999CA2330228A1 Angiostatin-binding protein
12/23/1999CA2330209A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999CA2329774A1 Genes for the biosynthesis of epothilones
12/23/1999CA2329689A1 Composition and method for treatment of pseudomonas
12/22/1999EP0965640A1 GP75 as a tumor vaccine for melanoma
12/22/1999EP0965639A1 Attenuated pestiviruses
12/22/1999EP0965638A2 G-CSF analog compositions and methods
12/22/1999EP0965637A1 Fas ANTIGEN DERIVATIVES
12/22/1999EP0965634A1 Novel primer and use thereof
12/22/1999EP0965597A1 Cell membrane-directed drugs
12/22/1999EP0965596A1 Method for elevating the concentration of free insulin-like growth factor
12/22/1999EP0965595A1 Protein complex
12/22/1999EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999EP0965041A1 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
12/22/1999EP0964930A1 Catalytic rna molecules
12/22/1999EP0964927A1 Cassava vein mosaic virus promoters and uses thereof
12/22/1999EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999EP0964924A1 Iron regulated promoter and uses thereof
12/22/1999EP0964920A1 Methods for improving seeds
12/22/1999EP0964916A1 Viral variants and methods for detecting same
12/22/1999EP0964914A1 Soybean cysteine proteinase inhibitors, nucleotides encoding the same, and methods of use thereof
12/22/1999EP0964874A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
12/22/1999EP0964873A1 Use of glucagon-like peptide-1 (glp-1) or analogs to abolish catabolic changes after surgery
12/22/1999EP0964872A1 Ftcd antigen
12/22/1999EP0964871A1 Synthetic bi-epitope compounds useful as standard measure in biological dosage of troponin i
12/22/1999EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999EP0964869A1 Methods and compositions for generating angiostatin
12/22/1999EP0964868A1 Isolated peptides derived from mage-2
12/22/1999EP0964740A1 Polyasparaginic acid homopolymers and copolymers, biotechnical production and use thereof
12/22/1999EP0964701A1 Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
12/22/1999EP0964699A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF
12/22/1999EP0964696A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
12/22/1999EP0964694A1 Mucin-mediated immunomodulation
12/22/1999EP0964693A1 Novel bacteriocins, transport and vector system and method of use thereof
12/22/1999EP0964691A1 Use of conantokins
12/22/1999EP0964689A1 Recombinant vaccine for diseases caused by encapsulated organisms
12/22/1999EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999EP0964617A1 Structure-based rational design of compounds to inhibit papillomavirus infection
12/22/1999EP0785992A4 Conditional transformation of genetically engineered cells
1 ... 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 ... 2916